Delivery Order SPE2DB24D1205-SPE2DB25FCYYK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,863.77 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on August 11, 2025, with completion targeted for August 12, 2025. This delivery order utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency awarded a $46,521.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL units). The contract was competitively awarded without set-aside designations and is scheduled for completion by June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $10,856.00 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injections on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $8,205.18 firm fixed price delivery order for Zepbound 15 mg/0.5 mL pen injectors, with an ultimate completion date of September 9, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role in supplying pharmaceutical products to federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $12,661.98 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, represents a continuation of the vendor's critical role in federal pharmaceutical procurement. The order will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,561.48 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injectors on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed price delivery order, which carries no set-aside designation, is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors with a ceiling value of $2,287.74. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 26, 2025, and no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,845.38 for Zepbound 2.5 mg/0.5 mL pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price contract, executed without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections, with a contract ceiling value of $12,962.38. This is a firm fixed price delivery order with an ultimate completion date of April 22, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.45 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injectors on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYYKDelivery Order
The Defense Logistics Agency awarded a $42,104.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on July 28, 2025, with completion targeted for July 29, 2025. This non-set-aside award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a comprehensive range of medications and medical supplies to Defense Health Agency and other federal healthcare systems through its DLA contract vehicle. The Zepbound delivery order fulfills federal pharmaceutical needs as part of the company's extensive portfolio supporting military healthcare programs globally. This competitively awarded transaction demonstrates AmerisourceBergen's ongoing capability to deliver specialized pharmaceutical products to meet federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.1k | 7/28/25 |